Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Fall;12(4):645-57.

Performance evaluation of a novel potentiometric membrane sensor for determination of atorvastatin in pharmaceutical preparations

Affiliations

Performance evaluation of a novel potentiometric membrane sensor for determination of atorvastatin in pharmaceutical preparations

Farhad Ahmadi et al. Iran J Pharm Res. 2013 Fall.

Abstract

A novel potentiometric ion-selective PVC membrane sensor for analysis of atorvastatin (AT) in pharmaceutical preparations based on atorvastatin-(tetraphenyl borate), (AT-(TPB)2) as sensing element, tetraphenyl borate as additive and tris-2-ethyl-hexyl phosphate (TOP) as plasticizer solvent was prepared. The electrode shows a good Nernestian response over the concentration range of 0.09-5586 μg mL(-1)of AT with slope of 30.1±0.1 mV/decade and limit of detection0.056μg mL(-1).The response time of sensor is fats (less than 10 sec) and could be used for about one month in the pH range of 4.5-8.0. The electrode exhibit good selectivity for the AT in the presence of large amount of co-drugs and inorganic cations. The method is precise and accurate with mean relative standard deviation of <2%.Atorvastatin is determined successfully in several tablets by the proposed membrane.

Keywords: Analysis of pharmaceutical preparation; Atorvastatin; PVC membrane; Potentiometric sensor.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Suggested structure of atorvastatin-tetraphenylborate (AT-(TPB)2) ionpair
Figure 2
Figure 2
Electrode response for AT prepared with AT-(TPB)2 ionpair as ionophore, the membrane contain of PVC:NaTPB:ionopher: TOP with 35:1.0:1.5:65%, respectively, the pH=4.0
Figure 3
Figure 3
Effect of pH of the test solution on the electrode potential reading, (●) 2234, (¡) 1.4and (▲) 0.14 μg mL-1AT solutions, the composition of membrane was like to the membrane NO.9
Figure 4
Figure 4
Variation of ˚Eelec with temperature
Figure 5
Figure 5
Dynamic response of the PVC membrane electrode based on AT-(TPB)2 for step change in activities of AT
Figure 6
Figure 6
Calibration curve of AT (μg mL-1) obtained with proposed electrode at optimum membrane composition and measurement conditions

Similar articles

Cited by

References

    1. Lea AP, Mc Tavish D, Atorvastatin A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias. Drugs. 1997;53:828–847. - PubMed
    1. Ness GC, Chambers CM, Lopez D. Atorvastatin action involves diminished recovery of hepatic HMG-CoA reductase activity. J. Lipid. 1998;39:75–84. - PubMed
    1. Conde K, Pineda G, Newton RS, Fernandez ML. Hypocholesterolemic effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in the guinea pig: Atorvastatin versus simvastatin. Biochem. Pharmacol. 1999;58:1209–1219. - PubMed
    1. Malek Mohamammd M, Fahimi F, Fakharian A, Karimi Gamishan M, Sistanizad M, Fayyazi N, Khalilzadeh S. Methacoline Challenge test as an Evaluator of Response to Statins in Bronchial Hyperresponsiveness. Iran. J. Pharm. Res. 2012;11:969–977. - PMC - PubMed
    1. Nawrocki JW, Weiss SR, Davidson MH, Sprecher DL, Schwartz SL, Lupien PJ, Jones PH, Haber HE, Black DM. Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor. Arterioscler. Thromb. Vasc. Biol. 1995;15:678–682. - PubMed

LinkOut - more resources